• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱浆细胞样尿路上皮癌:49例临床病理及免疫组化分析

Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases.

作者信息

Fox Melanie D, Xiao Li, Zhang Miao, Kamat Ashish M, Siefker-Radtke Arlene, Zhang Li, Dinney Colin P, Czerniak Bogdan, Guo Charles C

机构信息

Departments of Pathology.

Urology.

出版信息

Am J Clin Pathol. 2017 May 1;147(5):500-506. doi: 10.1093/ajcp/aqx029.

DOI:10.1093/ajcp/aqx029
PMID:28371875
Abstract

OBJECTIVES

Plasmacytoid urothelial carcinoma (PUC) of the bladder is a rare histologic variant. We retrospectively analyzed a large series of bladder PUC from a single institution.

METHODS

The patients consisted of 44 men and five women with a mean age of 62 years (range, 45-86 years).

RESULTS

PUC was pure in 23 cases and mixed with other histologic types in 26 cases. All PUCs diffusely invaded the bladder wall. Most PUCs lacked immunoreactivity for the retinoblastoma (RB) gene protein (12/32) and E-cadherin (8/30). Of the 44 patients with follow-up information, 25 died of PUC at a mean of 23 months, whereas 19 patients were alive at a mean of 22 months.

CONCLUSIONS

Our findings support that bladder PUC is a highly aggressive disease. The lack of E-cadherin expression in PUCs may underlie the distinct discohesive histologic appearance, and abnormal function of the RB gene may be implicated in the development of PUC.

摘要

目的

膀胱浆细胞样尿路上皮癌(PUC)是一种罕见的组织学变异类型。我们对来自单一机构的大量膀胱PUC病例进行了回顾性分析。

方法

患者包括44名男性和5名女性,平均年龄62岁(范围45 - 86岁)。

结果

23例为单纯PUC,26例与其他组织学类型混合。所有PUC均弥漫性侵犯膀胱壁。大多数PUC对视网膜母细胞瘤(RB)基因蛋白(12/32)和E - 钙黏蛋白(8/30)缺乏免疫反应性。在有随访信息的44例患者中,25例平均在23个月时死于PUC,而19例患者平均在22个月时仍存活。

结论

我们的研究结果支持膀胱PUC是一种高度侵袭性疾病。PUC中E - 钙黏蛋白表达的缺乏可能是其独特的分散性组织学外观的基础,而RB基因的异常功能可能与PUC的发生有关。

相似文献

1
Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases.膀胱浆细胞样尿路上皮癌:49例临床病理及免疫组化分析
Am J Clin Pathol. 2017 May 1;147(5):500-506. doi: 10.1093/ajcp/aqx029.
2
[Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases].[膀胱浆细胞样尿路上皮癌:16例临床病理研究]
Zhonghua Bing Li Xue Za Zhi. 2013 Jul;42(7):433-7. doi: 10.3760/cma.j.issn.0529-5807.2013.07.001.
3
Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder.膀胱浆细胞样尿路上皮癌中上皮-间充质转化相关标志物的表达。
BMC Urol. 2020 Jun 22;20(1):72. doi: 10.1186/s12894-020-00641-2.
4
Invasive plasmacytoid urothelial carcinoma: A comparative study of E-cadherin and P120 catenin.浸润性浆母细胞样尿路上皮癌:E-钙黏蛋白和 P120 连环蛋白的对比研究。
Hum Pathol. 2020 Aug;102:54-59. doi: 10.1016/j.humpath.2020.07.006. Epub 2020 Jul 13.
5
Metastatic Pleomorphic Lobular Carcinoma of the Breast to the Urinary Bladder: A Report of 10 Cases and Assessment of TRPS1 in the Differential Diagnosis With Plasmacytoid Urothelial Carcinoma.乳腺多形性小叶癌转移至膀胱:10 例报告,并评估 TRPS1 在与浆母细胞性尿路上皮癌鉴别诊断中的作用。
Arch Pathol Lab Med. 2024 Oct 1;148(10):1110-1118. doi: 10.5858/arpa.2023-0379-OA.
6
Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review.膀胱浆细胞样尿路上皮癌:一项临床病理研究及文献综述
Int J Clin Exp Pathol. 2012;5(6):601-8. Epub 2012 Jul 29.
7
Plasmacytoid urothelial carcinoma of the urinary bladder: a case report and immunohistochemical study.膀胱浆细胞样尿路上皮癌:一例报告及免疫组织化学研究
Pathol Res Pract. 2009;205(3):189-94. doi: 10.1016/j.prp.2008.09.004. Epub 2008 Nov 28.
8
Plasmacytoid urothelial carcinoma of the urinary bladder-A clinicopathological and molecular analysis of 52 cases.膀胱母细胞性尿路上皮癌-52 例的临床病理和分子分析。
Hum Pathol. 2024 Jun;148:1-6. doi: 10.1016/j.humpath.2024.04.012. Epub 2024 Apr 26.
9
Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients.浆细胞样/弥漫性尿路上皮癌:69 例患者的单机构免疫组织化学和分子研究。
Hum Pathol. 2019 Aug;90:27-36. doi: 10.1016/j.humpath.2019.04.012. Epub 2019 May 3.
10
Plasmacytoid urothelial carcinoma of the bladder.膀胱浆细胞样尿路上皮癌
Hum Pathol. 2009 Jul;40(7):1023-8. doi: 10.1016/j.humpath.2009.01.001. Epub 2009 Mar 17.

引用本文的文献

1
Simultaneous Lymphoepithelioma-Like and Plasmacytoid Subtypes of Urothelial Carcinoma, Along With Prostatic Adenocarcinoma With Clinical Follow-Up.尿路上皮癌的同时性淋巴上皮瘤样和浆细胞样亚型,以及前列腺腺癌伴临床随访
Case Rep Pathol. 2025 Aug 21;2025:9068792. doi: 10.1155/crip/9068792. eCollection 2025.
2
Plasmacytoid urothelial carcinoma: a multidisciplinary approach to the diagnosis and management.浆细胞样尿路上皮癌:诊断与管理的多学科方法
Abdom Radiol (NY). 2024 Sep 17. doi: 10.1007/s00261-024-04553-9.
3
Plasmacytoid urothelial carcinoma of the urinary bladder-A clinicopathological and molecular analysis of 52 cases.
膀胱母细胞性尿路上皮癌-52 例的临床病理和分子分析。
Hum Pathol. 2024 Jun;148:1-6. doi: 10.1016/j.humpath.2024.04.012. Epub 2024 Apr 26.
4
Molecular profile of bladder cancer progression to clinically aggressive subtypes.膀胱癌向临床侵袭性亚型进展的分子特征。
Nat Rev Urol. 2024 Jul;21(7):391-405. doi: 10.1038/s41585-023-00847-7. Epub 2024 Feb 6.
5
Molecular characterization of plasmacytoid urothelial carcinoma and the impact on treatment implications.浆细胞性尿路上皮癌的分子特征及其对治疗意义的影响。
Cancer Treat Res Commun. 2023;37:100779. doi: 10.1016/j.ctarc.2023.100779. Epub 2023 Nov 17.
6
The Many Faces of Urothelial Carcinomas: An Update From Pathology to Clinical Approach and Challenges in Practice.尿路上皮癌的多面性:从病理学到临床方法及实践挑战的最新进展
Urol Res Pract. 2023 May;49(3):147-161. doi: 10.5152/tud.2023.23023.
7
Plasmacytoid Variant Urothelial Cell Carcinoma: A Case of a Histological Variant of Urinary Bladder Cancer With Aggressive Behavior.浆细胞样变异型尿路上皮癌:1例具有侵袭性生物学行为的膀胱组织学变异型癌病例
Cureus. 2023 Mar 17;15(3):e36278. doi: 10.7759/cureus.36278. eCollection 2023 Mar.
8
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation.是否准备好在临床实践中实施膀胱癌的分子分型?第 2 部分:亚型和不同分化。
Int J Mol Sci. 2022 Jul 16;23(14):7844. doi: 10.3390/ijms23147844.
9
Outcomes of poorly differentiated and plasmacytoid variant bladder urothelial carcinoma.低分化和浆细胞样变异型膀胱尿路上皮癌的预后
BJUI Compass. 2021 Aug 27;3(1):62-67. doi: 10.1002/bco2.108. eCollection 2022 Jan.
10
Multiparametric magnetic resonance imaging of plasmacytoid urothelial carcinoma with histopathological correlation: A case report.浆细胞样尿路上皮癌的多参数磁共振成像与组织病理学相关性:病例报告
Radiol Case Rep. 2022 Apr 13;17(6):2155-2161. doi: 10.1016/j.radcr.2022.03.034. eCollection 2022 Jun.